BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/7/2019 7:09:17 AM | Browse: 131 | Download: 183
Publication Name World Journal of Gastroenterology
Manuscript ID 47845
Country/Territory Israel
2019-03-27 02:18
Peer-Review Started
2019-03-28 03:58
To Make the First Decision
2019-04-17 00:17
Return for Revision
2019-04-17 03:10
2019-05-29 19:07
Second Decision
2019-06-25 10:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2019-07-03 01:12
Articles in Press
2019-07-03 01:12
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2019-08-05 08:36
Publish the Manuscript Online
2019-08-07 07:09
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
Manuscript Source Invited Manuscript
All Author List Hadar Meringer, Oren Shibolet and Liat Deutsch
Author(s) ORCID Number
Hadar Meringer http://orcid.org/0000-0002-2624-2505
Oren Shibolet http://orcid.org/0000-0003-6111-5067
Liat Deutsch http://orcid.org/0000-0001-5022-4318
Funding Agency and Grant Number
Corresponding author Liat Deutsch, MD, Doctor, Department of Gastroenterology and Hepatology, Tel Aviv Sourasky Medical Center and the Sackler Faculty of Medicine, Tel Aviv University, 6 Weizmann St., Tel-Aviv 64239, Israel. liatml@tlvmc.gov.il
Keywords Hepatocellular carcinoma; Hepatitis C virus; Direct-acting antivirals; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis;
Core Tip Hepatocellular carcinoma (HCC) is a common and deadly malignancy. One of the leading risk factors for HCC occurrence is liver cirrhosis secondary to hepatitis C virus (HCV) infection. Direct-acting antiviral therapy has revolutionized HCV eradication due to high sustained virologic response rates. However, early reports argued an increased risk of HCC occurrence and recurrence. Recently, non-alcoholic fatty liver disease has become the most common liver disorder in Western countries and a major cause of HCC. We aimed to review the changes in HCC management in the face of the changing epidemiology in the post-HCV era.
Publish Date 2019-08-07 07:09
Citation Meringer H, Shibolet O, Deutsch L. Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? World J Gastroenterol 2019;25(29): 3929-3940
Url https://www.wjgnet.com/1007-9327/full/v25/i29/3929.htm
DOI https://dx.doi.org/10.3748/wjg.v25.i29.3929
Full Article (PDF) WJG-25-3929.pdf
Full Article (Word) WJG-25-3929.docx
Manuscript File 47845-Review.docx
Answering Reviewers 47845-Answering reviewers.pdf
Audio Core Tip 47845-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 47845-Conflict-of-interest statement.pdf
Copyright License Agreement 47845-Copyright license agreement.pdf
Non-Native Speakers of English Editing Certificate 47845-Language certificate.pdf
Peer-review Report 47845-Peer-review(s).pdf
Scientific Misconduct Check 47845-Scientific misconduct check.pdf
Scientific Editor Work List 47845-Scientific editor work list.pdf